Who Should Return for an Oral Glucose Tolerance Test? A Proposed Clinical Pathway Based on Retrospective Analysis of 332 Children Article Swipe
Sarah Wing-yiu Poon
,
Wilfred Hing Sang Wong
,
Anita Tsang
,
Grace Wing-kit Poon
,
Joanna Yuet‐ling Tung
·
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1210/jendso/bvab048.929
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1210/jendso/bvab048.929
Purpose: Fasting plasma glucose (FPG) or oral glucose tolerance test (OGTT) is the traditional diagnostic tool for type 2 diabetes (T2DM). Primary barrier to performing FPG or OGTT in asymptomatic patients is the requirement of fasting, and thus the need for another scheduled visit. For OGTT, at least 2 blood draws would be needed, making the test inconvenient and labour-intensive. These barriers may lead to lower testing rate and possibly under-diagnosis. In a busy clinic setting with increasing number of referrals for children with obesity, a more practical and simpler clinical pathway to stratify those at higher risk of having abnormal OGTT results from the lower risk ones is needed. This study thus aimed to identify simple non-fasting parameters which can be used to formulate a clinical pahtway to stratify subjects according to their risk of abnormal OGTT. Methods: This retrospective study included subjects with overweight or obesity who had undergone OGTT in tertiary paediatric unit from 2012–2018. The optimal haemoglobin A1c (HbA1c) cutoff that predicts abnormal OGTT was evaluated. Other non-fasting parameters, in combination with this HbA1c cutoff, were also explored as predictors of abnormal OGTT. Results: Three hundred and thirty-two subjects (boys: 54.2%, Chinese: 97.3%) were included for analysis, of which, 272 (81.9%) subjects had normal OGTT while 60 (18.0%) subjects had abnormal OGTT (prediabetes or T2DM). The mean age was 15.4 ± 2.3 years and the mean BMI z-score was 2.7 ± 0.6. The mean HbA1c level was significantly higher in the abnormal OGTT group than normal OGTT group (5.6% vs 5.3%, P<0.001). In our cohort, using the ADA criteria for prediabetes with a HbA1c cutoff of ≥ 5.7% only yielded a sensitivity of 41.7% and a specificity of 86% in identifying abnormal OGTT (prediabetes or T2DM), meaning that a substantial proportion of subjects with prediabetes or diabetes will be missed. From Receivers operating characteristic (ROC) curves analysis, optimal HbA1c predicting abnormal OGTT was 5.5% (AUC 0.71; sensitivity of 66.7% and specificity of 71%). When HbA1c ≥ 5.5% was combined with positive family history and abnormal alanine transaminase (ALT) level, the positive predictive value for abnormal OGTT was increased from 33.6% to 61.6%. Conclusion: In our cohort, over 97% were Chinese and close to 60% had family history of T2DM, thus fulfilling the ‘high-risk’ group criteria as suggested by American Diabetes Association to have FPG or OGTT screening. Nevertheless, only 18% of subjects had prediabetes or diabetes based on OGTT results. Our study showed that HbA1c, family history of T2DM and ALT level could be used to derive a clinical pathway to stratify children who have high risk of abnormal OGTT. These high risk individuals can go for further diagnostic tests, while those at lower risk of prediabetes/T2DM can avoid unnecessary tests and additional clinic visits.
Related Topics
Concepts
Medicine
Prediabetes
Asymptomatic
Internal medicine
Overweight
Diabetes mellitus
Retrospective cohort study
Obesity
Cutoff
Glucose tolerance test
Plasma glucose
Type 2 diabetes
Endocrinology
Insulin resistance
Physics
Quantum mechanics
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1210/jendso/bvab048.929
- https://academic.oup.com/jes/article-pdf/5/Supplement_1/A455/37205686/bvab048.929.pdf
- OA Status
- gold
- Cited By
- 1
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3159571496
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3159571496Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1210/jendso/bvab048.929Digital Object Identifier
- Title
-
Who Should Return for an Oral Glucose Tolerance Test? A Proposed Clinical Pathway Based on Retrospective Analysis of 332 ChildrenWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2021Year of publication
- Publication date
-
2021-05-01Full publication date if available
- Authors
-
Sarah Wing-yiu Poon, Wilfred Hing Sang Wong, Anita Tsang, Grace Wing-kit Poon, Joanna Yuet‐ling TungList of authors in order
- Landing page
-
https://doi.org/10.1210/jendso/bvab048.929Publisher landing page
- PDF URL
-
https://academic.oup.com/jes/article-pdf/5/Supplement_1/A455/37205686/bvab048.929.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://academic.oup.com/jes/article-pdf/5/Supplement_1/A455/37205686/bvab048.929.pdfDirect OA link when available
- Concepts
-
Medicine, Prediabetes, Asymptomatic, Internal medicine, Overweight, Diabetes mellitus, Retrospective cohort study, Obesity, Cutoff, Glucose tolerance test, Plasma glucose, Type 2 diabetes, Endocrinology, Insulin resistance, Physics, Quantum mechanicsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2023: 1Per-year citation counts (last 5 years)
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3159571496 |
|---|---|
| doi | https://doi.org/10.1210/jendso/bvab048.929 |
| ids.doi | https://doi.org/10.1210/jendso/bvab048.929 |
| ids.mag | 3159571496 |
| ids.openalex | https://openalex.org/W3159571496 |
| fwci | 0.09753243 |
| type | article |
| title | Who Should Return for an Oral Glucose Tolerance Test? A Proposed Clinical Pathway Based on Retrospective Analysis of 332 Children |
| biblio.issue | Supplement_1 |
| biblio.volume | 5 |
| biblio.last_page | A455 |
| biblio.first_page | A455 |
| topics[0].id | https://openalex.org/T11339 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9912999868392944 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1312 |
| topics[0].subfield.display_name | Molecular Biology |
| topics[0].display_name | Metabolism, Diabetes, and Cancer |
| topics[1].id | https://openalex.org/T10401 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9911999702453613 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2712 |
| topics[1].subfield.display_name | Endocrinology, Diabetes and Metabolism |
| topics[1].display_name | Diabetes Treatment and Management |
| topics[2].id | https://openalex.org/T10027 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9854999780654907 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2712 |
| topics[2].subfield.display_name | Endocrinology, Diabetes and Metabolism |
| topics[2].display_name | Diabetes, Cardiovascular Risks, and Lipoproteins |
| is_xpac | False |
| apc_list.value | 2822 |
| apc_list.currency | USD |
| apc_list.value_usd | 2822 |
| apc_paid.value | 2822 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2822 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8902958035469055 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2779668308 |
| concepts[1].level | 4 |
| concepts[1].score | 0.8213384747505188 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q2087205 |
| concepts[1].display_name | Prediabetes |
| concepts[2].id | https://openalex.org/C2777910003 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6987587809562683 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1707292 |
| concepts[2].display_name | Asymptomatic |
| concepts[3].id | https://openalex.org/C126322002 |
| concepts[3].level | 1 |
| concepts[3].score | 0.6134152412414551 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[3].display_name | Internal medicine |
| concepts[4].id | https://openalex.org/C2780586474 |
| concepts[4].level | 3 |
| concepts[4].score | 0.6098082661628723 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q332428 |
| concepts[4].display_name | Overweight |
| concepts[5].id | https://openalex.org/C555293320 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5750523209571838 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q12206 |
| concepts[5].display_name | Diabetes mellitus |
| concepts[6].id | https://openalex.org/C167135981 |
| concepts[6].level | 2 |
| concepts[6].score | 0.5422417521476746 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q2146302 |
| concepts[6].display_name | Retrospective cohort study |
| concepts[7].id | https://openalex.org/C511355011 |
| concepts[7].level | 2 |
| concepts[7].score | 0.505589485168457 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q12174 |
| concepts[7].display_name | Obesity |
| concepts[8].id | https://openalex.org/C2778217198 |
| concepts[8].level | 2 |
| concepts[8].score | 0.5049312710762024 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q556977 |
| concepts[8].display_name | Cutoff |
| concepts[9].id | https://openalex.org/C2780833929 |
| concepts[9].level | 4 |
| concepts[9].score | 0.4526309072971344 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q1501412 |
| concepts[9].display_name | Glucose tolerance test |
| concepts[10].id | https://openalex.org/C3020574416 |
| concepts[10].level | 3 |
| concepts[10].score | 0.4482078552246094 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q275157 |
| concepts[10].display_name | Plasma glucose |
| concepts[11].id | https://openalex.org/C2777180221 |
| concepts[11].level | 3 |
| concepts[11].score | 0.4045088291168213 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q3025883 |
| concepts[11].display_name | Type 2 diabetes |
| concepts[12].id | https://openalex.org/C134018914 |
| concepts[12].level | 1 |
| concepts[12].score | 0.26005643606185913 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[12].display_name | Endocrinology |
| concepts[13].id | https://openalex.org/C2777391703 |
| concepts[13].level | 3 |
| concepts[13].score | 0.22118180990219116 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q1053470 |
| concepts[13].display_name | Insulin resistance |
| concepts[14].id | https://openalex.org/C121332964 |
| concepts[14].level | 0 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q413 |
| concepts[14].display_name | Physics |
| concepts[15].id | https://openalex.org/C62520636 |
| concepts[15].level | 1 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q944 |
| concepts[15].display_name | Quantum mechanics |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8902958035469055 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/prediabetes |
| keywords[1].score | 0.8213384747505188 |
| keywords[1].display_name | Prediabetes |
| keywords[2].id | https://openalex.org/keywords/asymptomatic |
| keywords[2].score | 0.6987587809562683 |
| keywords[2].display_name | Asymptomatic |
| keywords[3].id | https://openalex.org/keywords/internal-medicine |
| keywords[3].score | 0.6134152412414551 |
| keywords[3].display_name | Internal medicine |
| keywords[4].id | https://openalex.org/keywords/overweight |
| keywords[4].score | 0.6098082661628723 |
| keywords[4].display_name | Overweight |
| keywords[5].id | https://openalex.org/keywords/diabetes-mellitus |
| keywords[5].score | 0.5750523209571838 |
| keywords[5].display_name | Diabetes mellitus |
| keywords[6].id | https://openalex.org/keywords/retrospective-cohort-study |
| keywords[6].score | 0.5422417521476746 |
| keywords[6].display_name | Retrospective cohort study |
| keywords[7].id | https://openalex.org/keywords/obesity |
| keywords[7].score | 0.505589485168457 |
| keywords[7].display_name | Obesity |
| keywords[8].id | https://openalex.org/keywords/cutoff |
| keywords[8].score | 0.5049312710762024 |
| keywords[8].display_name | Cutoff |
| keywords[9].id | https://openalex.org/keywords/glucose-tolerance-test |
| keywords[9].score | 0.4526309072971344 |
| keywords[9].display_name | Glucose tolerance test |
| keywords[10].id | https://openalex.org/keywords/plasma-glucose |
| keywords[10].score | 0.4482078552246094 |
| keywords[10].display_name | Plasma glucose |
| keywords[11].id | https://openalex.org/keywords/type-2-diabetes |
| keywords[11].score | 0.4045088291168213 |
| keywords[11].display_name | Type 2 diabetes |
| keywords[12].id | https://openalex.org/keywords/endocrinology |
| keywords[12].score | 0.26005643606185913 |
| keywords[12].display_name | Endocrinology |
| keywords[13].id | https://openalex.org/keywords/insulin-resistance |
| keywords[13].score | 0.22118180990219116 |
| keywords[13].display_name | Insulin resistance |
| language | en |
| locations[0].id | doi:10.1210/jendso/bvab048.929 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2735747656 |
| locations[0].source.issn | 2472-1972 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2472-1972 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Journal of the Endocrine Society |
| locations[0].source.host_organization | https://openalex.org/P4310315851 |
| locations[0].source.host_organization_name | Endocrine Society |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310315851 |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | https://academic.oup.com/jes/article-pdf/5/Supplement_1/A455/37205686/bvab048.929.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of the Endocrine Society |
| locations[0].landing_page_url | https://doi.org/10.1210/jendso/bvab048.929 |
| locations[1].id | pmh:oai:pubmedcentral.nih.gov:8089882 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S2764455111 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed Central |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | other-oa |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/other-oa |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | J Endocr Soc |
| locations[1].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/8089882 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5017779222 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-0818-9699 |
| authorships[0].author.display_name | Sarah Wing-yiu Poon |
| authorships[0].countries | HK |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I2800810863 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Hong Kong, Hong Kong |
| authorships[0].institutions[0].id | https://openalex.org/I2800810863 |
| authorships[0].institutions[0].ror | https://ror.org/02xkx3e48 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I1294586568, https://openalex.org/I2800810863 |
| authorships[0].institutions[0].country_code | HK |
| authorships[0].institutions[0].display_name | Queen Mary Hospital |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Sarah Wing-yiu Poon |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Hong Kong, Hong Kong |
| authorships[1].author.id | https://openalex.org/A5032402958 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-8396-2368 |
| authorships[1].author.display_name | Wilfred Hing Sang Wong |
| authorships[1].countries | HK |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I2800810863 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Hong Kong, Hong Kong |
| authorships[1].institutions[0].id | https://openalex.org/I2800810863 |
| authorships[1].institutions[0].ror | https://ror.org/02xkx3e48 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I1294586568, https://openalex.org/I2800810863 |
| authorships[1].institutions[0].country_code | HK |
| authorships[1].institutions[0].display_name | Queen Mary Hospital |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Wilfred Hing-sang Wong |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Hong Kong, Hong Kong |
| authorships[2].author.id | https://openalex.org/A5111108913 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Anita Tsang |
| authorships[2].countries | HK |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I2800810863 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Hong Kong, Hong Kong |
| authorships[2].institutions[0].id | https://openalex.org/I2800810863 |
| authorships[2].institutions[0].ror | https://ror.org/02xkx3e48 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I1294586568, https://openalex.org/I2800810863 |
| authorships[2].institutions[0].country_code | HK |
| authorships[2].institutions[0].display_name | Queen Mary Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Anita Man-ching Tsang |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Hong Kong, Hong Kong |
| authorships[3].author.id | https://openalex.org/A5007823436 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-5087-1478 |
| authorships[3].author.display_name | Grace Wing-kit Poon |
| authorships[3].countries | HK |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I2800810863 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Hong Kong, Hong Kong |
| authorships[3].institutions[0].id | https://openalex.org/I2800810863 |
| authorships[3].institutions[0].ror | https://ror.org/02xkx3e48 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I1294586568, https://openalex.org/I2800810863 |
| authorships[3].institutions[0].country_code | HK |
| authorships[3].institutions[0].display_name | Queen Mary Hospital |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Grace Wing-kit Poon |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Hong Kong, Hong Kong |
| authorships[4].author.id | https://openalex.org/A5083870897 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-7897-716X |
| authorships[4].author.display_name | Joanna Yuet‐ling Tung |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Paediatrics, Hong Kong Children’s Hospital, Hong Kong, Hong Kong |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Joanna Yuet-ling Tung |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Paediatrics, Hong Kong Children’s Hospital, Hong Kong, Hong Kong |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://academic.oup.com/jes/article-pdf/5/Supplement_1/A455/37205686/bvab048.929.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Who Should Return for an Oral Glucose Tolerance Test? A Proposed Clinical Pathway Based on Retrospective Analysis of 332 Children |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11339 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9912999868392944 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1312 |
| primary_topic.subfield.display_name | Molecular Biology |
| primary_topic.display_name | Metabolism, Diabetes, and Cancer |
| related_works | https://openalex.org/W2017317326, https://openalex.org/W2000722248, https://openalex.org/W1581380882, https://openalex.org/W2987126160, https://openalex.org/W2076332455, https://openalex.org/W2737615425, https://openalex.org/W2731692501, https://openalex.org/W2560293559, https://openalex.org/W2432405893, https://openalex.org/W3031236401 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2023 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1210/jendso/bvab048.929 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2735747656 |
| best_oa_location.source.issn | 2472-1972 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2472-1972 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Journal of the Endocrine Society |
| best_oa_location.source.host_organization | https://openalex.org/P4310315851 |
| best_oa_location.source.host_organization_name | Endocrine Society |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310315851 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | https://academic.oup.com/jes/article-pdf/5/Supplement_1/A455/37205686/bvab048.929.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of the Endocrine Society |
| best_oa_location.landing_page_url | https://doi.org/10.1210/jendso/bvab048.929 |
| primary_location.id | doi:10.1210/jendso/bvab048.929 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2735747656 |
| primary_location.source.issn | 2472-1972 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2472-1972 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Journal of the Endocrine Society |
| primary_location.source.host_organization | https://openalex.org/P4310315851 |
| primary_location.source.host_organization_name | Endocrine Society |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310315851 |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | https://academic.oup.com/jes/article-pdf/5/Supplement_1/A455/37205686/bvab048.929.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of the Endocrine Society |
| primary_location.landing_page_url | https://doi.org/10.1210/jendso/bvab048.929 |
| publication_date | 2021-05-01 |
| publication_year | 2021 |
| referenced_works_count | 0 |
| abstract_inverted_index.2 | 19, 49 |
| abstract_inverted_index.a | 73, 86, 126, 267, 275, 280, 293, 422 |
| abstract_inverted_index.60 | 211 |
| abstract_inverted_index.In | 72, 257, 358 |
| abstract_inverted_index.as | 183, 380 |
| abstract_inverted_index.at | 47, 96, 447 |
| abstract_inverted_index.be | 53, 122, 303, 418 |
| abstract_inverted_index.by | 382 |
| abstract_inverted_index.go | 440 |
| abstract_inverted_index.in | 29, 153, 174, 244, 284 |
| abstract_inverted_index.is | 12, 32, 109 |
| abstract_inverted_index.of | 35, 80, 99, 136, 185, 202, 270, 277, 282, 296, 322, 326, 372, 395, 412, 432, 450 |
| abstract_inverted_index.on | 402 |
| abstract_inverted_index.or | 6, 27, 147, 218, 289, 300, 389, 399 |
| abstract_inverted_index.to | 24, 65, 93, 115, 124, 129, 133, 355, 367, 386, 420, 425 |
| abstract_inverted_index.vs | 254 |
| abstract_inverted_index.± | 225, 235 |
| abstract_inverted_index.18% | 394 |
| abstract_inverted_index.2.3 | 226 |
| abstract_inverted_index.2.7 | 234 |
| abstract_inverted_index.272 | 204 |
| abstract_inverted_index.60% | 368 |
| abstract_inverted_index.86% | 283 |
| abstract_inverted_index.97% | 362 |
| abstract_inverted_index.A1c | 162 |
| abstract_inverted_index.ADA | 262 |
| abstract_inverted_index.ALT | 415 |
| abstract_inverted_index.BMI | 231 |
| abstract_inverted_index.FPG | 26, 388 |
| abstract_inverted_index.For | 45 |
| abstract_inverted_index.Our | 405 |
| abstract_inverted_index.The | 159, 220, 237 |
| abstract_inverted_index.age | 222 |
| abstract_inverted_index.and | 37, 59, 69, 89, 191, 228, 279, 324, 338, 365, 414, 456 |
| abstract_inverted_index.can | 121, 439, 452 |
| abstract_inverted_index.for | 17, 41, 82, 200, 264, 348, 441 |
| abstract_inverted_index.had | 150, 207, 214, 369, 397 |
| abstract_inverted_index.may | 63 |
| abstract_inverted_index.our | 258, 359 |
| abstract_inverted_index.the | 13, 33, 39, 56, 105, 229, 245, 261, 344, 376 |
| abstract_inverted_index.was | 169, 223, 233, 241, 317, 332, 351 |
| abstract_inverted_index.who | 149, 428 |
| abstract_inverted_index.≥ | 271, 330 |
| abstract_inverted_index.(AUC | 319 |
| abstract_inverted_index.0.6. | 236 |
| abstract_inverted_index.15.4 | 224 |
| abstract_inverted_index.5.5% | 318, 331 |
| abstract_inverted_index.5.7% | 272 |
| abstract_inverted_index.From | 305 |
| abstract_inverted_index.OGTT | 28, 102, 152, 168, 209, 216, 247, 251, 287, 316, 350, 390, 403 |
| abstract_inverted_index.T2DM | 413 |
| abstract_inverted_index.This | 111, 140 |
| abstract_inverted_index.When | 328 |
| abstract_inverted_index.also | 181 |
| abstract_inverted_index.busy | 74 |
| abstract_inverted_index.from | 104, 157, 353 |
| abstract_inverted_index.have | 387, 429 |
| abstract_inverted_index.high | 430, 436 |
| abstract_inverted_index.lead | 64 |
| abstract_inverted_index.mean | 221, 230, 238 |
| abstract_inverted_index.more | 87 |
| abstract_inverted_index.need | 40 |
| abstract_inverted_index.ones | 108 |
| abstract_inverted_index.only | 273, 393 |
| abstract_inverted_index.oral | 7 |
| abstract_inverted_index.over | 361 |
| abstract_inverted_index.rate | 68 |
| abstract_inverted_index.risk | 98, 107, 135, 431, 437, 449 |
| abstract_inverted_index.test | 10, 57 |
| abstract_inverted_index.than | 249 |
| abstract_inverted_index.that | 165, 292, 408 |
| abstract_inverted_index.this | 177 |
| abstract_inverted_index.thus | 38, 113, 374 |
| abstract_inverted_index.tool | 16 |
| abstract_inverted_index.type | 18 |
| abstract_inverted_index.unit | 156 |
| abstract_inverted_index.used | 123, 419 |
| abstract_inverted_index.were | 180, 198, 363 |
| abstract_inverted_index.will | 302 |
| abstract_inverted_index.with | 77, 84, 145, 176, 266, 298, 334 |
| abstract_inverted_index.(5.6% | 253 |
| abstract_inverted_index.(ALT) | 342 |
| abstract_inverted_index.(FPG) | 5 |
| abstract_inverted_index.(ROC) | 309 |
| abstract_inverted_index.0.71; | 320 |
| abstract_inverted_index.33.6% | 354 |
| abstract_inverted_index.41.7% | 278 |
| abstract_inverted_index.5.3%, | 255 |
| abstract_inverted_index.66.7% | 323 |
| abstract_inverted_index.71%). | 327 |
| abstract_inverted_index.HbA1c | 178, 239, 268, 313, 329 |
| abstract_inverted_index.OGTT, | 46 |
| abstract_inverted_index.OGTT. | 138, 187, 434 |
| abstract_inverted_index.Other | 171 |
| abstract_inverted_index.T2DM, | 373 |
| abstract_inverted_index.These | 61, 435 |
| abstract_inverted_index.Three | 189 |
| abstract_inverted_index.aimed | 114 |
| abstract_inverted_index.avoid | 453 |
| abstract_inverted_index.based | 401 |
| abstract_inverted_index.blood | 50 |
| abstract_inverted_index.close | 366 |
| abstract_inverted_index.could | 417 |
| abstract_inverted_index.draws | 51 |
| abstract_inverted_index.group | 248, 252, 378 |
| abstract_inverted_index.least | 48 |
| abstract_inverted_index.level | 240, 416 |
| abstract_inverted_index.lower | 66, 106, 448 |
| abstract_inverted_index.study | 112, 142, 406 |
| abstract_inverted_index.tests | 455 |
| abstract_inverted_index.their | 134 |
| abstract_inverted_index.those | 95, 446 |
| abstract_inverted_index.using | 260 |
| abstract_inverted_index.value | 347 |
| abstract_inverted_index.which | 120 |
| abstract_inverted_index.while | 210, 445 |
| abstract_inverted_index.would | 52 |
| abstract_inverted_index.years | 227 |
| abstract_inverted_index.(OGTT) | 11 |
| abstract_inverted_index.(boys: | 194 |
| abstract_inverted_index.54.2%, | 195 |
| abstract_inverted_index.61.6%. | 356 |
| abstract_inverted_index.97.3%) | 197 |
| abstract_inverted_index.HbA1c, | 409 |
| abstract_inverted_index.T2DM), | 290 |
| abstract_inverted_index.T2DM). | 219 |
| abstract_inverted_index.clinic | 75, 458 |
| abstract_inverted_index.curves | 310 |
| abstract_inverted_index.cutoff | 164, 269 |
| abstract_inverted_index.derive | 421 |
| abstract_inverted_index.family | 336, 370, 410 |
| abstract_inverted_index.having | 100 |
| abstract_inverted_index.higher | 97, 243 |
| abstract_inverted_index.level, | 343 |
| abstract_inverted_index.making | 55 |
| abstract_inverted_index.normal | 208, 250 |
| abstract_inverted_index.number | 79 |
| abstract_inverted_index.plasma | 3 |
| abstract_inverted_index.showed | 407 |
| abstract_inverted_index.simple | 117 |
| abstract_inverted_index.tests, | 444 |
| abstract_inverted_index.visit. | 44 |
| abstract_inverted_index.which, | 203 |
| abstract_inverted_index.(18.0%) | 212 |
| abstract_inverted_index.(81.9%) | 205 |
| abstract_inverted_index.(HbA1c) | 163 |
| abstract_inverted_index.(T2DM). | 21 |
| abstract_inverted_index.Chinese | 364 |
| abstract_inverted_index.Fasting | 2 |
| abstract_inverted_index.Primary | 22 |
| abstract_inverted_index.alanine | 340 |
| abstract_inverted_index.another | 42 |
| abstract_inverted_index.barrier | 23 |
| abstract_inverted_index.cohort, | 259, 360 |
| abstract_inverted_index.cutoff, | 179 |
| abstract_inverted_index.further | 442 |
| abstract_inverted_index.glucose | 4, 8 |
| abstract_inverted_index.history | 337, 371, 411 |
| abstract_inverted_index.hundred | 190 |
| abstract_inverted_index.meaning | 291 |
| abstract_inverted_index.missed. | 304 |
| abstract_inverted_index.needed, | 54 |
| abstract_inverted_index.needed. | 110 |
| abstract_inverted_index.obesity | 148 |
| abstract_inverted_index.optimal | 160, 312 |
| abstract_inverted_index.pahtway | 128 |
| abstract_inverted_index.pathway | 92, 424 |
| abstract_inverted_index.results | 103 |
| abstract_inverted_index.setting | 76 |
| abstract_inverted_index.simpler | 90 |
| abstract_inverted_index.testing | 67 |
| abstract_inverted_index.visits. | 459 |
| abstract_inverted_index.yielded | 274 |
| abstract_inverted_index.z-score | 232 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.American | 383 |
| abstract_inverted_index.Chinese: | 196 |
| abstract_inverted_index.Diabetes | 384 |
| abstract_inverted_index.Methods: | 139 |
| abstract_inverted_index.Purpose: | 1 |
| abstract_inverted_index.Results: | 188 |
| abstract_inverted_index.abnormal | 101, 137, 167, 186, 215, 246, 286, 315, 339, 349, 433 |
| abstract_inverted_index.barriers | 62 |
| abstract_inverted_index.children | 83, 427 |
| abstract_inverted_index.clinical | 91, 127, 423 |
| abstract_inverted_index.combined | 333 |
| abstract_inverted_index.criteria | 263, 379 |
| abstract_inverted_index.diabetes | 20, 301, 400 |
| abstract_inverted_index.explored | 182 |
| abstract_inverted_index.fasting, | 36 |
| abstract_inverted_index.identify | 116 |
| abstract_inverted_index.included | 143, 199 |
| abstract_inverted_index.obesity, | 85 |
| abstract_inverted_index.patients | 31 |
| abstract_inverted_index.positive | 335, 345 |
| abstract_inverted_index.possibly | 70 |
| abstract_inverted_index.predicts | 166 |
| abstract_inverted_index.results. | 404 |
| abstract_inverted_index.stratify | 94, 130, 426 |
| abstract_inverted_index.subjects | 131, 144, 193, 206, 213, 297, 396 |
| abstract_inverted_index.tertiary | 154 |
| abstract_inverted_index.Receivers | 306 |
| abstract_inverted_index.according | 132 |
| abstract_inverted_index.analysis, | 201, 311 |
| abstract_inverted_index.formulate | 125 |
| abstract_inverted_index.increased | 352 |
| abstract_inverted_index.operating | 307 |
| abstract_inverted_index.practical | 88 |
| abstract_inverted_index.referrals | 81 |
| abstract_inverted_index.scheduled | 43 |
| abstract_inverted_index.suggested | 381 |
| abstract_inverted_index.tolerance | 9 |
| abstract_inverted_index.undergone | 151 |
| abstract_inverted_index.additional | 457 |
| abstract_inverted_index.diagnostic | 15, 443 |
| abstract_inverted_index.evaluated. | 170 |
| abstract_inverted_index.fulfilling | 375 |
| abstract_inverted_index.increasing | 78 |
| abstract_inverted_index.overweight | 146 |
| abstract_inverted_index.paediatric | 155 |
| abstract_inverted_index.parameters | 119 |
| abstract_inverted_index.performing | 25 |
| abstract_inverted_index.predicting | 314 |
| abstract_inverted_index.predictive | 346 |
| abstract_inverted_index.predictors | 184 |
| abstract_inverted_index.proportion | 295 |
| abstract_inverted_index.screening. | 391 |
| abstract_inverted_index.thirty-two | 192 |
| abstract_inverted_index.Association | 385 |
| abstract_inverted_index.Conclusion: | 357 |
| abstract_inverted_index.combination | 175 |
| abstract_inverted_index.haemoglobin | 161 |
| abstract_inverted_index.identifying | 285 |
| abstract_inverted_index.individuals | 438 |
| abstract_inverted_index.non-fasting | 118, 172 |
| abstract_inverted_index.parameters, | 173 |
| abstract_inverted_index.prediabetes | 265, 299, 398 |
| abstract_inverted_index.requirement | 34 |
| abstract_inverted_index.sensitivity | 276, 321 |
| abstract_inverted_index.specificity | 281, 325 |
| abstract_inverted_index.substantial | 294 |
| abstract_inverted_index.traditional | 14 |
| abstract_inverted_index.unnecessary | 454 |
| abstract_inverted_index.(prediabetes | 217, 288 |
| abstract_inverted_index.2012–2018. | 158 |
| abstract_inverted_index.asymptomatic | 30 |
| abstract_inverted_index.inconvenient | 58 |
| abstract_inverted_index.transaminase | 341 |
| abstract_inverted_index.Nevertheless, | 392 |
| abstract_inverted_index.retrospective | 141 |
| abstract_inverted_index.significantly | 242 |
| abstract_inverted_index.characteristic | 308 |
| abstract_inverted_index.‘high-risk’ | 377 |
| abstract_inverted_index.P&lt;0.001). | 256 |
| abstract_inverted_index.prediabetes/T2DM | 451 |
| abstract_inverted_index.under-diagnosis. | 71 |
| abstract_inverted_index.labour-intensive. | 60 |
| cited_by_percentile_year.max | 94 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 5 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/8 |
| sustainable_development_goals[0].score | 0.6299999952316284 |
| sustainable_development_goals[0].display_name | Decent work and economic growth |
| citation_normalized_percentile.value | 0.42736722 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |